Pharma & Healthcare
Global Injection Influenza Vaccine Market Research Report 2025
- Nov 04, 25
- ID: 114083
- Pages: 97
- Figures: 91
- Views: 26
Report Scope
This report aims to provide a comprehensive presentation of the global market for Injection Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injection Influenza Vaccine.
The Injection Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Injection Influenza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, by Technology and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injection Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Technology and by regions.
By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Technology
Chicken Embryo Technology
Cell Culture Technology
Recombinant Technology
Adjuvanted Vaccines
Segment by Application
6 Months to 3 Years
> 3 Years
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injection Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injection Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Injection Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injection Influenza Vaccine.
The Injection Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Injection Influenza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, by Technology and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injection Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Technology and by regions.
By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Technology
Chicken Embryo Technology
Cell Culture Technology
Recombinant Technology
Adjuvanted Vaccines
Segment by Application
6 Months to 3 Years
> 3 Years
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injection Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injection Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Injection Influenza Vaccine Market Overview
1.1 Product Definition
1.2 Injection Influenza Vaccine by Type
1.2.1 Global Injection Influenza Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Injection Influenza Vaccine by Technology
1.3.1 Global Injection Influenza Vaccine Market Value Comparison by Technology: 2024 VS 2031
1.3.2 Chicken Embryo Technology
1.3.3 Cell Culture Technology
1.3.4 Recombinant Technology
1.3.5 Adjuvanted Vaccines
1.4 Injection Influenza Vaccine by Application
1.4.1 Global Injection Influenza Vaccine Market Value by Application (2024 VS 2031)
1.4.2 6 Months to 3 Years
1.4.3 > 3 Years
1.5 Global Injection Influenza Vaccine Market Size Estimates and Forecasts
1.5.1 Global Injection Influenza Vaccine Revenue 2020-2031
1.5.2 Global Injection Influenza Vaccine Sales 2020-2031
1.5.3 Global Injection Influenza Vaccine Market Average Price (2020-2031)
1.6 Assumptions and Limitations
2 Injection Influenza Vaccine Market Competition by Manufacturers
2.1 Global Injection Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Injection Influenza Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Injection Influenza Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Injection Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injection Influenza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injection Influenza Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Injection Influenza Vaccine, Date of Enter into This Industry
2.8 Global Injection Influenza Vaccine Market Competitive Situation and Trends
2.8.1 Global Injection Influenza Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Injection Influenza Vaccine Players Market Share by Revenue
2.8.3 Global Injection Influenza Vaccine Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Injection Influenza Vaccine Market Scenario by Region
3.1 Global Injection Influenza Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Injection Influenza Vaccine Sales by Region: 2020-2031
3.2.1 Global Injection Influenza Vaccine Sales by Region: 2020-2025
3.2.2 Global Injection Influenza Vaccine Sales by Region: 2026-2031
3.3 Global Injection Influenza Vaccine Revenue by Region: 2020-2031
3.3.1 Global Injection Influenza Vaccine Revenue by Region: 2020-2025
3.3.2 Global Injection Influenza Vaccine Revenue by Region: 2026-2031
3.4 North America Injection Influenza Vaccine Market Facts & Figures by Country
3.4.1 North America Injection Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Injection Influenza Vaccine Sales by Country (2020-2031)
3.4.3 North America Injection Influenza Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Injection Influenza Vaccine Market Facts & Figures by Country
3.5.1 Europe Injection Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Injection Influenza Vaccine Sales by Country (2020-2031)
3.5.3 Europe Injection Influenza Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injection Influenza Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Injection Influenza Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Injection Influenza Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Injection Influenza Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Injection Influenza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Injection Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Injection Influenza Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Injection Influenza Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injection Influenza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Injection Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Injection Influenza Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Injection Influenza Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Injection Influenza Vaccine Sales by Type (2020-2031)
4.1.1 Global Injection Influenza Vaccine Sales by Type (2020-2025)
4.1.2 Global Injection Influenza Vaccine Sales by Type (2026-2031)
4.1.3 Global Injection Influenza Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Injection Influenza Vaccine Revenue by Type (2020-2031)
4.2.1 Global Injection Influenza Vaccine Revenue by Type (2020-2025)
4.2.2 Global Injection Influenza Vaccine Revenue by Type (2026-2031)
4.2.3 Global Injection Influenza Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Injection Influenza Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Injection Influenza Vaccine Sales by Application (2020-2031)
5.1.1 Global Injection Influenza Vaccine Sales by Application (2020-2025)
5.1.2 Global Injection Influenza Vaccine Sales by Application (2026-2031)
5.1.3 Global Injection Influenza Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Injection Influenza Vaccine Revenue by Application (2020-2031)
5.2.1 Global Injection Influenza Vaccine Revenue by Application (2020-2025)
5.2.2 Global Injection Influenza Vaccine Revenue by Application (2026-2031)
5.2.3 Global Injection Influenza Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Injection Influenza Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Injection Influenza Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Injection Influenza Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Injection Influenza Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Viatris Injection Influenza Vaccine Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Company Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AstraZeneca Injection Influenza Vaccine Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Company Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hualan Bio Injection Influenza Vaccine Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.7.1 Changchun Institute of Biological Company Information
6.7.2 Changchun Institute of Biological Description and Business Overview
6.7.3 Changchun Institute of Biological Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Changchun Institute of Biological Injection Influenza Vaccine Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Company Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sinovac Injection Influenza Vaccine Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 BCHT
6.9.1 BCHT Company Information
6.9.2 BCHT Description and Business Overview
6.9.3 BCHT Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BCHT Injection Influenza Vaccine Product Portfolio
6.9.5 BCHT Recent Developments/Updates
6.10 Jiangsu GDK
6.10.1 Jiangsu GDK Company Information
6.10.2 Jiangsu GDK Description and Business Overview
6.10.3 Jiangsu GDK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jiangsu GDK Injection Influenza Vaccine Product Portfolio
6.10.5 Jiangsu GDK Recent Developments/Updates
6.11 KM Biologics
6.11.1 KM Biologics Company Information
6.11.2 KM Biologics Description and Business Overview
6.11.3 KM Biologics Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 KM Biologics Injection Influenza Vaccine Product Portfolio
6.11.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injection Influenza Vaccine Industry Chain Analysis
7.2 Injection Influenza Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injection Influenza Vaccine Production Mode & Process Analysis
7.4 Injection Influenza Vaccine Sales and Marketing
7.4.1 Injection Influenza Vaccine Sales Channels
7.4.2 Injection Influenza Vaccine Distributors
7.5 Injection Influenza Vaccine Customer Analysis
8 Injection Influenza Vaccine Market Dynamics
8.1 Injection Influenza Vaccine Industry Trends
8.2 Injection Influenza Vaccine Market Drivers
8.3 Injection Influenza Vaccine Market Challenges
8.4 Injection Influenza Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Injection Influenza Vaccine by Type
1.2.1 Global Injection Influenza Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Injection Influenza Vaccine by Technology
1.3.1 Global Injection Influenza Vaccine Market Value Comparison by Technology: 2024 VS 2031
1.3.2 Chicken Embryo Technology
1.3.3 Cell Culture Technology
1.3.4 Recombinant Technology
1.3.5 Adjuvanted Vaccines
1.4 Injection Influenza Vaccine by Application
1.4.1 Global Injection Influenza Vaccine Market Value by Application (2024 VS 2031)
1.4.2 6 Months to 3 Years
1.4.3 > 3 Years
1.5 Global Injection Influenza Vaccine Market Size Estimates and Forecasts
1.5.1 Global Injection Influenza Vaccine Revenue 2020-2031
1.5.2 Global Injection Influenza Vaccine Sales 2020-2031
1.5.3 Global Injection Influenza Vaccine Market Average Price (2020-2031)
1.6 Assumptions and Limitations
2 Injection Influenza Vaccine Market Competition by Manufacturers
2.1 Global Injection Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Injection Influenza Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Injection Influenza Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Injection Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injection Influenza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injection Influenza Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Injection Influenza Vaccine, Date of Enter into This Industry
2.8 Global Injection Influenza Vaccine Market Competitive Situation and Trends
2.8.1 Global Injection Influenza Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Injection Influenza Vaccine Players Market Share by Revenue
2.8.3 Global Injection Influenza Vaccine Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Injection Influenza Vaccine Market Scenario by Region
3.1 Global Injection Influenza Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Injection Influenza Vaccine Sales by Region: 2020-2031
3.2.1 Global Injection Influenza Vaccine Sales by Region: 2020-2025
3.2.2 Global Injection Influenza Vaccine Sales by Region: 2026-2031
3.3 Global Injection Influenza Vaccine Revenue by Region: 2020-2031
3.3.1 Global Injection Influenza Vaccine Revenue by Region: 2020-2025
3.3.2 Global Injection Influenza Vaccine Revenue by Region: 2026-2031
3.4 North America Injection Influenza Vaccine Market Facts & Figures by Country
3.4.1 North America Injection Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Injection Influenza Vaccine Sales by Country (2020-2031)
3.4.3 North America Injection Influenza Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Injection Influenza Vaccine Market Facts & Figures by Country
3.5.1 Europe Injection Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Injection Influenza Vaccine Sales by Country (2020-2031)
3.5.3 Europe Injection Influenza Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injection Influenza Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Injection Influenza Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Injection Influenza Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Injection Influenza Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Injection Influenza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Injection Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Injection Influenza Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Injection Influenza Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injection Influenza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Injection Influenza Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Injection Influenza Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Injection Influenza Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Injection Influenza Vaccine Sales by Type (2020-2031)
4.1.1 Global Injection Influenza Vaccine Sales by Type (2020-2025)
4.1.2 Global Injection Influenza Vaccine Sales by Type (2026-2031)
4.1.3 Global Injection Influenza Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Injection Influenza Vaccine Revenue by Type (2020-2031)
4.2.1 Global Injection Influenza Vaccine Revenue by Type (2020-2025)
4.2.2 Global Injection Influenza Vaccine Revenue by Type (2026-2031)
4.2.3 Global Injection Influenza Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Injection Influenza Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Injection Influenza Vaccine Sales by Application (2020-2031)
5.1.1 Global Injection Influenza Vaccine Sales by Application (2020-2025)
5.1.2 Global Injection Influenza Vaccine Sales by Application (2026-2031)
5.1.3 Global Injection Influenza Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Injection Influenza Vaccine Revenue by Application (2020-2031)
5.2.1 Global Injection Influenza Vaccine Revenue by Application (2020-2025)
5.2.2 Global Injection Influenza Vaccine Revenue by Application (2026-2031)
5.2.3 Global Injection Influenza Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Injection Influenza Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Injection Influenza Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Injection Influenza Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Injection Influenza Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Viatris Injection Influenza Vaccine Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Company Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AstraZeneca Injection Influenza Vaccine Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Company Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hualan Bio Injection Influenza Vaccine Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.7.1 Changchun Institute of Biological Company Information
6.7.2 Changchun Institute of Biological Description and Business Overview
6.7.3 Changchun Institute of Biological Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Changchun Institute of Biological Injection Influenza Vaccine Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Company Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sinovac Injection Influenza Vaccine Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 BCHT
6.9.1 BCHT Company Information
6.9.2 BCHT Description and Business Overview
6.9.3 BCHT Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BCHT Injection Influenza Vaccine Product Portfolio
6.9.5 BCHT Recent Developments/Updates
6.10 Jiangsu GDK
6.10.1 Jiangsu GDK Company Information
6.10.2 Jiangsu GDK Description and Business Overview
6.10.3 Jiangsu GDK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jiangsu GDK Injection Influenza Vaccine Product Portfolio
6.10.5 Jiangsu GDK Recent Developments/Updates
6.11 KM Biologics
6.11.1 KM Biologics Company Information
6.11.2 KM Biologics Description and Business Overview
6.11.3 KM Biologics Injection Influenza Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 KM Biologics Injection Influenza Vaccine Product Portfolio
6.11.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injection Influenza Vaccine Industry Chain Analysis
7.2 Injection Influenza Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injection Influenza Vaccine Production Mode & Process Analysis
7.4 Injection Influenza Vaccine Sales and Marketing
7.4.1 Injection Influenza Vaccine Sales Channels
7.4.2 Injection Influenza Vaccine Distributors
7.5 Injection Influenza Vaccine Customer Analysis
8 Injection Influenza Vaccine Market Dynamics
8.1 Injection Influenza Vaccine Industry Trends
8.2 Injection Influenza Vaccine Market Drivers
8.3 Injection Influenza Vaccine Market Challenges
8.4 Injection Influenza Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Injection Influenza Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Injection Influenza Vaccine Market Value by Technology, (US$ Million) & (2024 VS 2031)
Table 3. Global Injection Influenza Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 4. Global Injection Influenza Vaccine Market Competitive Situation by Manufacturers in 2024
Table 5. Global Injection Influenza Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 6. Global Injection Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Injection Influenza Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 8. Global Injection Influenza Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Global Market Injection Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 10. Global Key Players of Injection Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 11. Global Key Manufacturers of Injection Influenza Vaccine, Manufacturing Sites & Headquarters
Table 12. Global Key Manufacturers of Injection Influenza Vaccine, Product Type & Application
Table 13. Global Key Manufacturers of Injection Influenza Vaccine, Date of Enter into This Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Injection Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injection Influenza Vaccine as of 2024)
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global Injection Influenza Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Injection Influenza Vaccine Sales by Region (2020-2025) & (K Units)
Table 19. Global Injection Influenza Vaccine Sales Market Share by Region (2020-2025)
Table 20. Global Injection Influenza Vaccine Sales by Region (2026-2031) & (K Units)
Table 21. Global Injection Influenza Vaccine Sales Market Share by Region (2026-2031)
Table 22. Global Injection Influenza Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 23. Global Injection Influenza Vaccine Revenue Market Share by Region (2020-2025)
Table 24. Global Injection Influenza Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 25. Global Injection Influenza Vaccine Revenue Market Share by Region (2026-2031)
Table 26. North America Injection Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 27. North America Injection Influenza Vaccine Sales by Country (2020-2025) & (K Units)
Table 28. North America Injection Influenza Vaccine Sales by Country (2026-2031) & (K Units)
Table 29. North America Injection Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 30. North America Injection Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 31. Europe Injection Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 32. Europe Injection Influenza Vaccine Sales by Country (2020-2025) & (K Units)
Table 33. Europe Injection Influenza Vaccine Sales by Country (2026-2031) & (K Units)
Table 34. Europe Injection Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 35. Europe Injection Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 36. Asia Pacific Injection Influenza Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 37. Asia Pacific Injection Influenza Vaccine Sales by Region (2020-2025) & (K Units)
Table 38. Asia Pacific Injection Influenza Vaccine Sales by Region (2026-2031) & (K Units)
Table 39. Asia Pacific Injection Influenza Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 40. Asia Pacific Injection Influenza Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 41. Latin America Injection Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 42. Latin America Injection Influenza Vaccine Sales by Country (2020-2025) & (K Units)
Table 43. Latin America Injection Influenza Vaccine Sales by Country (2026-2031) & (K Units)
Table 44. Latin America Injection Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 45. Latin America Injection Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 46. Middle East and Africa Injection Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 47. Middle East and Africa Injection Influenza Vaccine Sales by Country (2020-2025) & (K Units)
Table 48. Middle East and Africa Injection Influenza Vaccine Sales by Country (2026-2031) & (K Units)
Table 49. Middle East and Africa Injection Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 50. Middle East and Africa Injection Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 51. Global Injection Influenza Vaccine Sales (K Units) by Type (2020-2025)
Table 52. Global Injection Influenza Vaccine Sales (K Units) by Type (2026-2031)
Table 53. Global Injection Influenza Vaccine Sales Market Share by Type (2020-2025)
Table 54. Global Injection Influenza Vaccine Sales Market Share by Type (2026-2031)
Table 55. Global Injection Influenza Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 56. Global Injection Influenza Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 57. Global Injection Influenza Vaccine Revenue Market Share by Type (2020-2025)
Table 58. Global Injection Influenza Vaccine Revenue Market Share by Type (2026-2031)
Table 59. Global Injection Influenza Vaccine Price (US$/Unit) by Type (2020-2025)
Table 60. Global Injection Influenza Vaccine Price (US$/Unit) by Type (2026-2031)
Table 61. Global Injection Influenza Vaccine Sales (K Units) by Application (2020-2025)
Table 62. Global Injection Influenza Vaccine Sales (K Units) by Application (2026-2031)
Table 63. Global Injection Influenza Vaccine Sales Market Share by Application (2020-2025)
Table 64. Global Injection Influenza Vaccine Sales Market Share by Application (2026-2031)
Table 65. Global Injection Influenza Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 66. Global Injection Influenza Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 67. Global Injection Influenza Vaccine Revenue Market Share by Application (2020-2025)
Table 68. Global Injection Influenza Vaccine Revenue Market Share by Application (2026-2031)
Table 69. Global Injection Influenza Vaccine Price (US$/Unit) by Application (2020-2025)
Table 70. Global Injection Influenza Vaccine Price (US$/Unit) by Application (2026-2031)
Table 71. Sanofi Company Information
Table 72. Sanofi Description and Business Overview
Table 73. Sanofi Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 74. Sanofi Injection Influenza Vaccine Product
Table 75. Sanofi Recent Developments/Updates
Table 76. CSL Company Information
Table 77. CSL Description and Business Overview
Table 78. CSL Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 79. CSL Injection Influenza Vaccine Product
Table 80. CSL Recent Developments/Updates
Table 81. GSK Company Information
Table 82. GSK Description and Business Overview
Table 83. GSK Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 84. GSK Injection Influenza Vaccine Product
Table 85. GSK Recent Developments/Updates
Table 86. Viatris Company Information
Table 87. Viatris Description and Business Overview
Table 88. Viatris Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 89. Viatris Injection Influenza Vaccine Product
Table 90. Viatris Recent Developments/Updates
Table 91. AstraZeneca Company Information
Table 92. AstraZeneca Description and Business Overview
Table 93. AstraZeneca Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 94. AstraZeneca Injection Influenza Vaccine Product
Table 95. AstraZeneca Recent Developments/Updates
Table 96. Hualan Bio Company Information
Table 97. Hualan Bio Description and Business Overview
Table 98. Hualan Bio Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Hualan Bio Injection Influenza Vaccine Product
Table 100. Hualan Bio Recent Developments/Updates
Table 101. Changchun Institute of Biological Company Information
Table 102. Changchun Institute of Biological Description and Business Overview
Table 103. Changchun Institute of Biological Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Changchun Institute of Biological Injection Influenza Vaccine Product
Table 105. Changchun Institute of Biological Recent Developments/Updates
Table 106. Sinovac Company Information
Table 107. Sinovac Description and Business Overview
Table 108. Sinovac Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Sinovac Injection Influenza Vaccine Product
Table 110. Sinovac Recent Developments/Updates
Table 111. BCHT Company Information
Table 112. BCHT Description and Business Overview
Table 113. BCHT Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. BCHT Injection Influenza Vaccine Product
Table 115. BCHT Recent Developments/Updates
Table 116. Jiangsu GDK Company Information
Table 117. Jiangsu GDK Description and Business Overview
Table 118. Jiangsu GDK Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Jiangsu GDK Injection Influenza Vaccine Product
Table 120. Jiangsu GDK Recent Developments/Updates
Table 121. KM Biologics Company Information
Table 122. KM Biologics Description and Business Overview
Table 123. KM Biologics Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. KM Biologics Injection Influenza Vaccine Product
Table 125. KM Biologics Recent Developments/Updates
Table 126. Key Raw Materials Lists
Table 127. Raw Materials Key Suppliers Lists
Table 128. Injection Influenza Vaccine Distributors List
Table 129. Injection Influenza Vaccine Customers List
Table 130. Injection Influenza Vaccine Market Trends
Table 131. Injection Influenza Vaccine Market Drivers
Table 132. Injection Influenza Vaccine Market Challenges
Table 133. Injection Influenza Vaccine Market Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
Table 137. Authors List of This Report
List of Figures
Figure 1. Product Picture of Injection Influenza Vaccine
Figure 2. Global Injection Influenza Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Injection Influenza Vaccine Market Share by Type: 2024 & 2031
Figure 4. Trivalent Influenza Vaccine Product Picture
Figure 5. Quadrivalent Influenza Vaccine Product Picture
Figure 6. Global Injection Influenza Vaccine Market Value by Technology, (US$ Million) & (2020-2031)
Figure 7. Global Injection Influenza Vaccine Market Share by Technology: 2024 VS 2031
Figure 8. Chicken Embryo Technology Product Picture
Figure 9. Cell Culture Technology Product Picture
Figure 10. Recombinant Technology Product Picture
Figure 11. Adjuvanted Vaccines Product Picture
Figure 12. Global Injection Influenza Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 13. Global Injection Influenza Vaccine Market Share by Application: 2024 & 2031
Figure 14. 6 Months to 3 Years
Figure 15. > 3 Years
Figure 16. Global Injection Influenza Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Injection Influenza Vaccine Market Size (2020-2031) & (US$ Million)
Figure 18. Global Injection Influenza Vaccine Sales (2020-2031) & (K Units)
Figure 19. Global Injection Influenza Vaccine Average Price (US$/Unit) & (2020-2031)
Figure 20. Injection Influenza Vaccine Report Years Considered
Figure 21. Injection Influenza Vaccine Sales Share by Manufacturers in 2024
Figure 22. Global Injection Influenza Vaccine Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Injection Influenza Vaccine Players: Market Share by Revenue in Injection Influenza Vaccine in 2024
Figure 24. Injection Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Injection Influenza Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Injection Influenza Vaccine Sales Market Share by Country (2020-2031)
Figure 27. North America Injection Influenza Vaccine Revenue Market Share by Country (2020-2031)
Figure 28. U.S. Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Injection Influenza Vaccine Sales Market Share by Country (2020-2031)
Figure 31. Europe Injection Influenza Vaccine Revenue Market Share by Country (2020-2031)
Figure 32. Germany Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Injection Influenza Vaccine Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Injection Influenza Vaccine Revenue Market Share by Region (2020-2031)
Figure 39. China Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Taiwan Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Philippines Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America Injection Influenza Vaccine Sales Market Share by Country (2020-2031)
Figure 50. Latin America Injection Influenza Vaccine Revenue Market Share by Country (2020-2031)
Figure 51. Mexico Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Middle East and Africa Injection Influenza Vaccine Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Injection Influenza Vaccine Revenue Market Share by Country (2020-2031)
Figure 56. Turkey Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. U.A.E Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Global Sales Market Share of Injection Influenza Vaccine by Type (2020-2031)
Figure 60. Global Revenue Market Share of Injection Influenza Vaccine by Type (2020-2031)
Figure 61. Global Injection Influenza Vaccine Price (US$/Unit) by Type (2020-2031)
Figure 62. Global Sales Market Share of Injection Influenza Vaccine by Application (2020-2031)
Figure 63. Global Revenue Market Share of Injection Influenza Vaccine by Application (2020-2031)
Figure 64. Global Injection Influenza Vaccine Price (US$/Unit) by Application (2020-2031)
Figure 65. Injection Influenza Vaccine Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global Injection Influenza Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Injection Influenza Vaccine Market Value by Technology, (US$ Million) & (2024 VS 2031)
Table 3. Global Injection Influenza Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 4. Global Injection Influenza Vaccine Market Competitive Situation by Manufacturers in 2024
Table 5. Global Injection Influenza Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 6. Global Injection Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Injection Influenza Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 8. Global Injection Influenza Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Global Market Injection Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 10. Global Key Players of Injection Influenza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 11. Global Key Manufacturers of Injection Influenza Vaccine, Manufacturing Sites & Headquarters
Table 12. Global Key Manufacturers of Injection Influenza Vaccine, Product Type & Application
Table 13. Global Key Manufacturers of Injection Influenza Vaccine, Date of Enter into This Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Injection Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injection Influenza Vaccine as of 2024)
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global Injection Influenza Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Injection Influenza Vaccine Sales by Region (2020-2025) & (K Units)
Table 19. Global Injection Influenza Vaccine Sales Market Share by Region (2020-2025)
Table 20. Global Injection Influenza Vaccine Sales by Region (2026-2031) & (K Units)
Table 21. Global Injection Influenza Vaccine Sales Market Share by Region (2026-2031)
Table 22. Global Injection Influenza Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 23. Global Injection Influenza Vaccine Revenue Market Share by Region (2020-2025)
Table 24. Global Injection Influenza Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 25. Global Injection Influenza Vaccine Revenue Market Share by Region (2026-2031)
Table 26. North America Injection Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 27. North America Injection Influenza Vaccine Sales by Country (2020-2025) & (K Units)
Table 28. North America Injection Influenza Vaccine Sales by Country (2026-2031) & (K Units)
Table 29. North America Injection Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 30. North America Injection Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 31. Europe Injection Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 32. Europe Injection Influenza Vaccine Sales by Country (2020-2025) & (K Units)
Table 33. Europe Injection Influenza Vaccine Sales by Country (2026-2031) & (K Units)
Table 34. Europe Injection Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 35. Europe Injection Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 36. Asia Pacific Injection Influenza Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 37. Asia Pacific Injection Influenza Vaccine Sales by Region (2020-2025) & (K Units)
Table 38. Asia Pacific Injection Influenza Vaccine Sales by Region (2026-2031) & (K Units)
Table 39. Asia Pacific Injection Influenza Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 40. Asia Pacific Injection Influenza Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 41. Latin America Injection Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 42. Latin America Injection Influenza Vaccine Sales by Country (2020-2025) & (K Units)
Table 43. Latin America Injection Influenza Vaccine Sales by Country (2026-2031) & (K Units)
Table 44. Latin America Injection Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 45. Latin America Injection Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 46. Middle East and Africa Injection Influenza Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 47. Middle East and Africa Injection Influenza Vaccine Sales by Country (2020-2025) & (K Units)
Table 48. Middle East and Africa Injection Influenza Vaccine Sales by Country (2026-2031) & (K Units)
Table 49. Middle East and Africa Injection Influenza Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 50. Middle East and Africa Injection Influenza Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 51. Global Injection Influenza Vaccine Sales (K Units) by Type (2020-2025)
Table 52. Global Injection Influenza Vaccine Sales (K Units) by Type (2026-2031)
Table 53. Global Injection Influenza Vaccine Sales Market Share by Type (2020-2025)
Table 54. Global Injection Influenza Vaccine Sales Market Share by Type (2026-2031)
Table 55. Global Injection Influenza Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 56. Global Injection Influenza Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 57. Global Injection Influenza Vaccine Revenue Market Share by Type (2020-2025)
Table 58. Global Injection Influenza Vaccine Revenue Market Share by Type (2026-2031)
Table 59. Global Injection Influenza Vaccine Price (US$/Unit) by Type (2020-2025)
Table 60. Global Injection Influenza Vaccine Price (US$/Unit) by Type (2026-2031)
Table 61. Global Injection Influenza Vaccine Sales (K Units) by Application (2020-2025)
Table 62. Global Injection Influenza Vaccine Sales (K Units) by Application (2026-2031)
Table 63. Global Injection Influenza Vaccine Sales Market Share by Application (2020-2025)
Table 64. Global Injection Influenza Vaccine Sales Market Share by Application (2026-2031)
Table 65. Global Injection Influenza Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 66. Global Injection Influenza Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 67. Global Injection Influenza Vaccine Revenue Market Share by Application (2020-2025)
Table 68. Global Injection Influenza Vaccine Revenue Market Share by Application (2026-2031)
Table 69. Global Injection Influenza Vaccine Price (US$/Unit) by Application (2020-2025)
Table 70. Global Injection Influenza Vaccine Price (US$/Unit) by Application (2026-2031)
Table 71. Sanofi Company Information
Table 72. Sanofi Description and Business Overview
Table 73. Sanofi Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 74. Sanofi Injection Influenza Vaccine Product
Table 75. Sanofi Recent Developments/Updates
Table 76. CSL Company Information
Table 77. CSL Description and Business Overview
Table 78. CSL Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 79. CSL Injection Influenza Vaccine Product
Table 80. CSL Recent Developments/Updates
Table 81. GSK Company Information
Table 82. GSK Description and Business Overview
Table 83. GSK Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 84. GSK Injection Influenza Vaccine Product
Table 85. GSK Recent Developments/Updates
Table 86. Viatris Company Information
Table 87. Viatris Description and Business Overview
Table 88. Viatris Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 89. Viatris Injection Influenza Vaccine Product
Table 90. Viatris Recent Developments/Updates
Table 91. AstraZeneca Company Information
Table 92. AstraZeneca Description and Business Overview
Table 93. AstraZeneca Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 94. AstraZeneca Injection Influenza Vaccine Product
Table 95. AstraZeneca Recent Developments/Updates
Table 96. Hualan Bio Company Information
Table 97. Hualan Bio Description and Business Overview
Table 98. Hualan Bio Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Hualan Bio Injection Influenza Vaccine Product
Table 100. Hualan Bio Recent Developments/Updates
Table 101. Changchun Institute of Biological Company Information
Table 102. Changchun Institute of Biological Description and Business Overview
Table 103. Changchun Institute of Biological Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Changchun Institute of Biological Injection Influenza Vaccine Product
Table 105. Changchun Institute of Biological Recent Developments/Updates
Table 106. Sinovac Company Information
Table 107. Sinovac Description and Business Overview
Table 108. Sinovac Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Sinovac Injection Influenza Vaccine Product
Table 110. Sinovac Recent Developments/Updates
Table 111. BCHT Company Information
Table 112. BCHT Description and Business Overview
Table 113. BCHT Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. BCHT Injection Influenza Vaccine Product
Table 115. BCHT Recent Developments/Updates
Table 116. Jiangsu GDK Company Information
Table 117. Jiangsu GDK Description and Business Overview
Table 118. Jiangsu GDK Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Jiangsu GDK Injection Influenza Vaccine Product
Table 120. Jiangsu GDK Recent Developments/Updates
Table 121. KM Biologics Company Information
Table 122. KM Biologics Description and Business Overview
Table 123. KM Biologics Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. KM Biologics Injection Influenza Vaccine Product
Table 125. KM Biologics Recent Developments/Updates
Table 126. Key Raw Materials Lists
Table 127. Raw Materials Key Suppliers Lists
Table 128. Injection Influenza Vaccine Distributors List
Table 129. Injection Influenza Vaccine Customers List
Table 130. Injection Influenza Vaccine Market Trends
Table 131. Injection Influenza Vaccine Market Drivers
Table 132. Injection Influenza Vaccine Market Challenges
Table 133. Injection Influenza Vaccine Market Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
Table 137. Authors List of This Report
List of Figures
Figure 1. Product Picture of Injection Influenza Vaccine
Figure 2. Global Injection Influenza Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Injection Influenza Vaccine Market Share by Type: 2024 & 2031
Figure 4. Trivalent Influenza Vaccine Product Picture
Figure 5. Quadrivalent Influenza Vaccine Product Picture
Figure 6. Global Injection Influenza Vaccine Market Value by Technology, (US$ Million) & (2020-2031)
Figure 7. Global Injection Influenza Vaccine Market Share by Technology: 2024 VS 2031
Figure 8. Chicken Embryo Technology Product Picture
Figure 9. Cell Culture Technology Product Picture
Figure 10. Recombinant Technology Product Picture
Figure 11. Adjuvanted Vaccines Product Picture
Figure 12. Global Injection Influenza Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 13. Global Injection Influenza Vaccine Market Share by Application: 2024 & 2031
Figure 14. 6 Months to 3 Years
Figure 15. > 3 Years
Figure 16. Global Injection Influenza Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Injection Influenza Vaccine Market Size (2020-2031) & (US$ Million)
Figure 18. Global Injection Influenza Vaccine Sales (2020-2031) & (K Units)
Figure 19. Global Injection Influenza Vaccine Average Price (US$/Unit) & (2020-2031)
Figure 20. Injection Influenza Vaccine Report Years Considered
Figure 21. Injection Influenza Vaccine Sales Share by Manufacturers in 2024
Figure 22. Global Injection Influenza Vaccine Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Injection Influenza Vaccine Players: Market Share by Revenue in Injection Influenza Vaccine in 2024
Figure 24. Injection Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Injection Influenza Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Injection Influenza Vaccine Sales Market Share by Country (2020-2031)
Figure 27. North America Injection Influenza Vaccine Revenue Market Share by Country (2020-2031)
Figure 28. U.S. Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Injection Influenza Vaccine Sales Market Share by Country (2020-2031)
Figure 31. Europe Injection Influenza Vaccine Revenue Market Share by Country (2020-2031)
Figure 32. Germany Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Injection Influenza Vaccine Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Injection Influenza Vaccine Revenue Market Share by Region (2020-2031)
Figure 39. China Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Taiwan Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Philippines Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America Injection Influenza Vaccine Sales Market Share by Country (2020-2031)
Figure 50. Latin America Injection Influenza Vaccine Revenue Market Share by Country (2020-2031)
Figure 51. Mexico Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Middle East and Africa Injection Influenza Vaccine Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Injection Influenza Vaccine Revenue Market Share by Country (2020-2031)
Figure 56. Turkey Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. U.A.E Injection Influenza Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Global Sales Market Share of Injection Influenza Vaccine by Type (2020-2031)
Figure 60. Global Revenue Market Share of Injection Influenza Vaccine by Type (2020-2031)
Figure 61. Global Injection Influenza Vaccine Price (US$/Unit) by Type (2020-2031)
Figure 62. Global Sales Market Share of Injection Influenza Vaccine by Application (2020-2031)
Figure 63. Global Revenue Market Share of Injection Influenza Vaccine by Application (2020-2031)
Figure 64. Global Injection Influenza Vaccine Price (US$/Unit) by Application (2020-2031)
Figure 65. Injection Influenza Vaccine Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232